COMPANY PROFILE

Longyao Biotech

Explore full profile

A biotechnology company specializing in the advancement of tumor immune cell technology and related products

Huangpu, ChinaFounded 2013Biotech & Life Sciences

Valuation $50–100M Last recorded · 2023

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Longyao Biotech

Longyao Biotech is a national high-tech enterprise dedicated to the research and development of innovative biotechnological solutions, particularly in the fields of hematological and solid tumors. The company operates in the biotechnology sector, focusing on developing advanced treatments and therapies for cancer patients. Longyao Biotech primarily serves healthcare providers, hospitals, and research institutions that require cutting-edge solutions for cancer treatment. Longyao Biotech's business model revolves around the development and commercialization of proprietary biotechnological products and therapies. The company generates revenue through the sale of its products, licensing agreements, and partnerships with other healthcare organizations. One of its notable achievements includes the successful completion of a Phase I clinical trial for relapsed refractory CD20 positive B cell non-Hodgkin's lymphoma, demonstrating its commitment to overcoming significant medical challenges.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2013
Headquarters: Huangpu, China
Employees: 8
Open positions: None listed
Dealroom signal: 34.1/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

2 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
LATE VC✓Equity / VC	Dec 2023	$14M	$55M	China Biotech Services Holdings	↗
SPINOUT✓Other financing	Jan 2013	$0	—	Shanghai Jiao Tong University	↗

Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Longyao Biotech website traffic

Latest recorded traffic for Longyao Biotech is 1.1K monthly website visits, up 1122.2% over the last three months. Longyao Biotech's team declined 11.1% over the past year.

Latest monthly visits1.1K 3-month web change+1122.2% 1-year team growth-11.1%

Monthly website visitsFeb 2024–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
SASansanimaHuman cell-based assays replacing animal testing.	Sheffield, United Kingdom	Operational	5	$396K	$1.6M
GAGametoA new breed of biotechnology company focused on understanding and eliminating infertility and menopause	New York City, United States	Operational
AVAviadoBioPrecision gene therapies for neurodegenerative disorders	London, United Kingdom	Operational
MTMuvon TherapeuticsMuvon Therapeutics is creating an autologous cell therapy for damaged skeletal muscles in SUI patients, with a primary focus on developing a safe treatment for stress urinary incontinence in women	Zurich, Switzerland	Operational
MBMyricx BioNovel antibody-drug conjugate payloads for cancer treatment	London, United Kingdom	Acquired
ADAdaptateDeveloping therapeutic antibodies to modulate gamma delta T cell activity for innovative immunotherapy solutions	London, United Kingdom	Acquired
VBViaNautis BioPolymer nanoparticle platform for targeted intracellular genetic delivery	Cambridge, United Kingdom	Operational
KTKeapstone TherapeuticsSmall molecule activators for neurodegenerative disease therapies	Sheffield, United Kingdom	Operational